James Fung on Muck Rack

James Fung

Canada
As seen in: IMDb, MSN Canada, Color Research & Application, Wiley Online Library, PS, JoVE- Journal of Visualized Experiments, Sing Tao Daily, Clinical Gastroenterology and Hepatology
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with James

Contact James, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Bronchial Artery-Pulmonary Artery Fistula With Dual Arterial Feeders Treated Successfully With Staged Embolisation Procedures-A Case Report

|
By Hei-Shun Cheng, James Fung, Kevin Chin, Chi-Chung Jeffrey Wong
| Wiley Online Library Verified
1 Introduction Bronchial artery-pulmonary artery fistula (BPAF) receives its arterial supply from bronchial artery (BA) with drainage into pulmonary artery. Contrary to the right-to-left shunt in pulmonary arteriovenous malformation (PAVM), BPAF demonstrates a left-to-right shunt. Given this anatomical distinction, it manifests differently from PAVM both clinically and radiologically.
Open in Who Shared Issue with article?

Development and Validation of a High‐Sensitivity Droplet Digital PCR Assay for Serum Hepatitis B Virus DNA Detection

|
By Rex Wan-Hin Hui, Danny Wong, Lung-Yi Mak, James Fung
| Wiley Online Library Verified
1 Introduction Hepatitis B virus (HBV) DNA is an important biomarker in the management of chronic hepatitis B (CHB), as it reflects viral replication, guides treatment decisions, and predicts long-term risks of liver-related complications [1]. Real-time polymerase chain reaction (PCR) is the current standard for serum HBV DNA detection, with multiple commercial assays available. Despite the widespread use of real-time PCR, it is not without limitations.
Open in Who Shared Issue with article?

Editorial: Mitigating the risk of severe hepatitis flare following nucleoside analogue discontinuation—Insights from a real‐world study

|
By Lung-Yi Mak, James Fung
| Wiley Online Library Verified
The current treatment endpoint for chronic hepatitis B (CHB) infection is functional cure, defined as sustained hepatitis B surface antigen (HBsAg) seroclearance. Due to the low incidence of achieving functional cure (1–2%/year), new treatment strategies are being explored. The ‘stop-to-cure’ approach has been extensively evaluated, as viral rebound after nucleoside analogue discontinuation may activate immune-mediated elimination of virus-infected hepatocytes.
Open in Who Shared Issue with article?
See all 12 articles
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified